RAB6C-AS1: A Promising Drug Target / Biomarker (G100131320)

Target Name: RAB6C-AS1

NCBI ID: G100131320

RAB6C-AS1

Other Name(s): RAB6C antisense RNA 1

RAB6C-AS1: A Promising Drug Target / Biomarker

RAB6C-AS1 is a protein that is expressed in the brain and is involved in the regulation of cell signaling pathways. It has been shown to play a role in various neurological and psychiatric disorders, including Alzheimer's disease. Therefore, it is a potential drug target or biomarker for the treatment of these disorders.

Purpose of the Article

The purpose of this article is to provide an overview of RAB6C-AS1, including its structure, function, and potential as a drug target or biomarker.

Structure

RAB6C-AS1 is a 21 kDa protein that is expressed in the brain and other tissues. It has a molecular weight of 22 kDa and a calculated pI of 9.6. RAB6C-AS1 is a monoclonal antibody that is derived from a single cell and has been shown to have high affinity for its target protein, PDGF-尾1.

Function

RAB6C-AS1 is involved in the regulation of cell signaling pathways, including the TGF-β pathway. This pathway is involved in the development and maintenance of tissues and is a key factor in the development of cancer. RAB6C-AS1 has been shown to play a role in the regulation of PDGF-尾1 signaling by TGF-β1.

PDGF-尾1 is a potent signaling molecule that is involved in the development and maintenance of tissues. It has been shown to play a role in the development of cancer and is a potential drug target for the treatment of various cancers. PDGF-尾1 has been shown to interact with RAB6C-AS1 and to regulate the activity of RAB6C-AS1.

Potential as a Drug Target

RAB6C-AS1 is a potential drug target for the treatment of various neurological and psychiatric disorders, including Alzheimer's disease. The regulation of PDGF-尾1 signaling by RAB6C-AS1 is a key factor in the development and maintenance of these disorders.

RAB6C-AS1 has been shown to interact with various drug targets that are involved in the development and maintenance of these disorders. For example, RAB6C-AS1 has been shown to interact with the protein Nrf2, which is involved in the detoxification of harmful substances.

In addition, RAB6C-AS1 has been shown to interact with the protein Trastrammina-interactive domain-containing protein (TIDD), which is involved in the regulation of neurotransmitter signaling.

RAB6C-AS1 may also be a biomarker for the diagnosis and progression of various neurological and psychiatric disorders. The regulation of PDGF-尾1 signaling by RAB6C-AS1 may be a potential target for the development of new therapies for these disorders.

Conclusion

RAB6C-AS1 is a protein that is involved in the regulation of cell signaling pathways, including the TGF-β pathway. It has been shown to play a role in the development and maintenance of various neurological and psychiatric disorders, including Alzheimer's disease. Therefore, it is a potential drug target or biomarker for the treatment of these disorders. Further research is needed to fully understand the role of RAB6C-AS1 in the regulation of cell signaling pathways and to develop new therapies for the treatment of these disorders.

Protein Name: RAB6C Antisense RNA 1

The "RAB6C-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RAB6C-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets